Position statement: global neuraminidase inhibitor susceptibility network - PubMed (original) (raw)
Review
Position statement: global neuraminidase inhibitor susceptibility network
M Zambon et al. Antiviral Res. 2001 Mar.
No abstract available
Similar articles
- Influenza virus neuraminidase inhibitors.
Gubareva LV, Kaiser L, Hayden FG. Gubareva LV, et al. Lancet. 2000 Mar 4;355(9206):827-35. doi: 10.1016/S0140-6736(99)11433-8. Lancet. 2000. PMID: 10711940 Review. - Neuraminidase inhibitors and relief of influenza symptoms.
Lemon M, Meade F. Lemon M, et al. S D J Med. 2000 Mar;53(3):99-100. S D J Med. 2000. PMID: 10745653 No abstract available. - Neuraminidase inhibitors for influenza.
Moscona A. Moscona A. N Engl J Med. 2005 Sep 29;353(13):1363-73. doi: 10.1056/NEJMra050740. N Engl J Med. 2005. PMID: 16192481 Review. No abstract available. - Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia.
Hurt AC, Barr IG, Durrant CJ, Shaw RP, Sjogren HM, Hampson AW. Hurt AC, et al. Commun Dis Intell Q Rep. 2003;27(4):542-7. Commun Dis Intell Q Rep. 2003. PMID: 15508516 - [Neuraminidase inhibitor].
Kaji M. Kaji M. Nihon Rinsho. 2000 Nov;58(11):2293-8. Nihon Rinsho. 2000. PMID: 11225320 Review. Japanese.
Cited by
- Global Challenges with Oral Antivirals for COVID-19.
Smith DJ, Hakim AJ, Taylor A, Bennett SD, Patel P, Greiner A, Marston BJ. Smith DJ, et al. Popul Health Manag. 2022 Dec;25(6):822-827. doi: 10.1089/pop.2022.0171. Epub 2022 Oct 31. Popul Health Manag. 2022. PMID: 36315439 Free PMC article. - Intervention Strategies for Seasonal and Emerging Respiratory Viruses with Drugs and Vaccines Targeting Viral Surface Glycoproteins.
Tripp RA, Stambas J. Tripp RA, et al. Viruses. 2021 Apr 6;13(4):625. doi: 10.3390/v13040625. Viruses. 2021. PMID: 33917411 Free PMC article. Review. - Differential Viral-Host Immune Interactions Associated with Oseltamivir-Resistant H275Y and Wild-Type H1N1 A(pdm09) Influenza Virus Pathogenicity.
Vidaña B, Martínez-Orellana P, Martorell JM, Baratelli M, Martínez J, Migura-Garcia L, Córdoba L, Pérez M, Casas I, Pozo F, Fraile L, Majó N, Montoya M. Vidaña B, et al. Viruses. 2020 Jul 24;12(8):794. doi: 10.3390/v12080794. Viruses. 2020. PMID: 32721992 Free PMC article. - Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016-2017.
Lackenby A, Besselaar TG, Daniels RS, Fry A, Gregory V, Gubareva LV, Huang W, Hurt AC, Leang SK, Lee RTC, Lo J, Lollis L, Maurer-Stroh S, Odagiri T, Pereyaslov D, Takashita E, Wang D, Zhang W, Meijer A. Lackenby A, et al. Antiviral Res. 2018 Sep;157:38-46. doi: 10.1016/j.antiviral.2018.07.001. Epub 2018 Jul 3. Antiviral Res. 2018. PMID: 29981793 Free PMC article. - Drug resistance in influenza A virus: the epidemiology and management.
Hussain M, Galvin HD, Haw TY, Nutsford AN, Husain M. Hussain M, et al. Infect Drug Resist. 2017 Apr 20;10:121-134. doi: 10.2147/IDR.S105473. eCollection 2017. Infect Drug Resist. 2017. PMID: 28458567 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical